SpectraCure AB (OSTO:SPEC) Common Stock: kr57.06 Mil (As of Mar. 2026)


What is SpectraCure AB Common Stock?

SpectraCure AB OSTO:SPEC +1.58% Common Stock is kr57.06 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

SpectraCure AB's quarterly common stock stayed the same from Sep. 2025 (kr40.97 Mil) to Dec. 2025 (kr40.97 Mil) but then increased from Dec. 2025 (kr40.97 Mil) to Mar. 2026 (kr57.06 Mil).

SpectraCure AB's annual common stock stayed the same from Dec. 2023 (kr9.71 Mil) to Dec. 2024 (kr9.71 Mil) but then increased from Dec. 2024 (kr9.71 Mil) to Dec. 2025 (kr40.97 Mil).

SpectraCure AB Common Stock Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB Common Stock Chart

SpectraCure AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.71 9.71 9.71 9.71 40.97

SpectraCure AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.71 40.97 40.97 40.97 57.06

SpectraCure AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr57.06 Mil mean?
SpectraCure AB (OSTO:SPEC) has a Common Stock of kr57.06 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SpectraCure AB and its competitors.
Is SpectraCure AB's Common Stock too high?
SpectraCure AB's current Common Stock is kr57.06 Mil.
How does SpectraCure AB's Common Stock compare to ABT and SYK?
SpectraCure AB's Common Stock of kr57.06 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current Common Stock is kr57.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Common Stock of kr57.06 Mil. The current Common Stock is kr57.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Common Stock is kr57.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.